Next Article in Journal
Two Decades of Disease Evolution and Biomarker-Guided Clinical Decision Making in Metastatic Prostate Cancer
Previous Article in Journal
GNR: Genetic-Embedded Nuclear Reaction Optimization with F-Score Filter for Gene Selection in Cancer Classification
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

The Effect of Intracellular Calcium Buffer Bapta on Epileptiform Activity of Hippocampal Neurons

1
Federal Research Center “Pushchino Scientific Center for Biological Research of the Russian Academy of Sciences”, Institute of Cell Biophysics of the Russian Academy of Sciences, Pushchino 142290, Russia
2
Faculty of Biology and Biotechnology, Al-Farabi Kazakh National University, Almaty 050040, Kazakhstan
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2025, 26(15), 7596; https://doi.org/10.3390/ijms26157596
Submission received: 28 June 2025 / Revised: 25 July 2025 / Accepted: 29 July 2025 / Published: 6 August 2025
(This article belongs to the Section Molecular Neurobiology)

Abstract

The rhythm of epileptiform activity occurs in various brain injuries (ischemia, stroke, concussion, mechanical damage, AD, PD). The epileptiform rhythm is accompanied by periodic Ca2+ pulses, which are necessary for the neurotransmitter release, the repair of damaged connections between neurons, and the growth of new projections. The duration and amplitude of these pulses depend on intracellular calcium-binding proteins. The effect of the synthetic fast calcium buffer BAPTA on the epileptiform activity of neurons induced by the GABA(A)-receptor inhibitor, bicuculline, was investigated in a 14-DIV rat hippocampal culture. In the epileptiform activity mode, neurons periodically synchronously generate action potential (AP) bursts in the form of paroxysmal depolarization shift (PDS) clusters and their corresponding high-amplitude Ca2+ pulses. Changes in the paroxysmal activity and Ca2+ pulses were recorded continuously for 10–11 min as BAPTA accumulated. It was shown that during BAPTA accumulation, transformation of neuronal patch activity occurs. Moreover, GABAergic and glutamatergic neurons respond differently to the presence of calcium buffer. Experiments were performed on two populations of neurons: a population of GABAergic neurons that responded selectively to ATPA, a calcium-permeable GluK1 kainate receptor agonist, and a population of glutamatergic neurons with a large amplitude of cluster depolarization (greater than −20 mV). These neurons made up the majority of neurons. In the population of GABAergic neurons, during BAPTA accumulation, the amplitude of PDS clusters decreases, which leads to a switch from the PDS mode to the classical burst mode with an increase in the electrical activity of the neuron. In glutamatergic neurons, the duration of PDS clusters decreased during BAPTA accumulation. However, the amplitude changed little. The data obtained showed that endogenous calcium-binding proteins play a significant role in switching the epileptiform rhythm to the recovery rhythm and perform a neuroprotective function by reducing the duration of impulses in excitatory neurons and the amplitude of impulses in inhibitory neurons.

1. Introduction

Generally, the epileptiform activity of brain neurons refers to the rhythm of interictal brain activity that is observed between epileptic seizures. In epileptiform neuronal activity, the normal bursting electrical activity is transformed into a paroxysmal depolarizing shift (PDS) cluster activity [1]. PDS clusters have a complex structure that contains in addition to two oscillation systems (fast oscillations of AP and slow oscillations of AP bursts), a third, little studied oscillation system, PDS. All three oscillatory systems include a set of potential- and ligand-dependent ion channels, the sequential opening and closing of which forms such a complex electrical signal—the PDS cluster. Importantly, this type of brain neuron activity has been observed not only in epilepsy but also in stroke, Alzheimer’s disease (AD), Parkinson’s disease (PD) [2,3], mechanical damage, concussion, and early periods of brain development [4,5].
According to the World Health Organization (WHO), tens of millions of people suffer from various neurological disorders worldwide. Approximately 50–70 million people have epilepsy [6]. Parkinson’s disease affects approximately 1% of the population over the age of 60 years, and grows to 4% at the age of 80 years [7,8]. Sixty-nine million individuals worldwide are estimated to sustain a traumatic brain injury each year [9]. Stroke is the third highest cause of morbidity and mortality in many countries of the world, following ischemic heart disease and malignant diseases [10]. Approximately 1% of the global population (50–70 million people) have epilepsy [11]. It has been suggested that rhythm is necessary to repair damage and establish new connections between neurons [12]. Understanding the mechanisms underlying changes in the amplitude and frequency of the rhythm can help us control the aforementioned processes. Therefore, the current task is not only to suppress hyperactivity in pathologies, but to switch the rhythm of epileptiform activity into the rhythm of the development/restoration of damaged contacts.
Ca2+ ions regulate many processes in the cell and are one of the main regulators of neuronal bursting activity. They do this both directly by binding to targets and indirectly by binding to Ca2+-binding proteins: parvalbumin, calmodulin, S100 proteins and calcineurin, calreticulin, and calsequestrin [13,14]. It has been shown that the generation of AP bursts during epileptiform activity is accompanied by Ca2+ impulses [15]. It is known that the amplitude and shape of calcium impulses depend on the concentration of intracellular calcium-binding proteins (CBPs), which can delay or eliminate the effect of Ca2+ on transmitter release or on excitation [16].
Calretinin and calbindin belong to fast Ca2+-binding proteins [17], and are found in some subtypes of neurons in buffer concentrations [18]. The action of such CBPs can be mimicked by using a synthetic analog, BAPTA [19]. The esterified form of BAPTA-AM added to the cell incubation medium slowly (within 10 min) accumulates in cells, where the ester bonds are hydrolyzed by intracellular esterases, gradually increasing the Ca2+ buffer concentration. Since Kd for Ca2+ = 0.2 μM, the presence of BAPTA does not change the steady-state values of cytosolic Ca2+ concentration ([Ca2+]i), but may reduce the amplitude and smooth out Ca2+ pulses during epileptiform activity of the neuron. The concentration of BAPTA-AM was selected experimentally. In other experiments, BAPTA was used at concentrations of 10, 25, and 50 μM. Lower concentrations did not affect the pulse parameters, while higher concentrations caused rapid inhibition of pulsations. The relationship between the dose and the effect of intracellular BAPTA is evident when BAPTA is accumulated during the experiment.
Calcium currents, unlike sodium and potassium currents, significantly change the [Ca2+]i during the PDS clusters generation, which is necessary for the neurotransmitters release. However, the role of Ca2+ concentration and CBP in the regulation of PDS clusters and in rhythmogenesis in different types of neurons during epileptiform activity is poorly understood.

2. Results

2.1. Selection of Neurons. ATPA-Sensitive GABAergic Neurons

It was previously shown that in the mode of epileptiform activity induced by the GABA(A)-receptor inhibitor bicuculline in hippocampal cell culture, neurons generate bursts of AP in the form of PDS clusters, which differ in amplitude and frequency [20].
We investigated the effect of BAPTA on two groups of neurons. We chose glutamatergic neurons with a large cluster depolarization amplitude (greater than −20 mV), in which all Na+-channels were inactivated after the first AP. Such neurons constituted the majority in the culture (Figure 1A).
Among the inhibitory neurons, we selected neurons that responded specifically to the (RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid (ATPA), a selective agonist of the GLU(K5) receptor subtype (Figure 1B). Previous studies have shown that these neurons are GABAergic and express calcium-permeable kainate receptors (CP-KARs) [21,22,23].
A standard experiment to identify ATPA-sensitive neurons is shown in Figure 2A. In an initially spontaneously pulsed hippocampal neuronal culture, a near-maximal dose of ATPA caused a [Ca2+]i increase in GABAergic neurons (highlighted in red). Glutamatergic neurons are indicated by other blue-green-gray colors. ATPA-induced elevation of [Ca2+]i causes GABA release [24] and inhibits [Ca2+]i pulses in innervated glutamate neurons (Figure 2B). The subsequent addition of bicuculline largely reverses the effects of GABA, inducing epileptiform activity in the form of synchronized PDS cluster oscillations in all neurons. The amplitude of impulses in most neurons increases compared to the control before supplementation. BAPTA increases the amplitude of [Ca2+]i oscillations in glutamatergic neurons (gray curves) and decreases them in GABAergic neurons (Figure 2A).

2.2. The Effect of BAPTA on PDS Clusters During Epileptiform Neuronal Activity

The effect of BAPTA was studied in glutamate and GABAergic neurons, which were selected based on the above-mentioned characteristics. The resting membrane potential of GABAergic and glutamatergic neurons did not differ significantly and averaged −65 mV. The membrane potential at which the Na+ current was generated in GABAergic neurons was −55 mV on average and required a small depolarization to activate it. In contrast, glutamatergic neurons were activated at an average of −42 mV and required a strong depolarization. Figure 3 and Figure 4 show changes in the membrane potentials of two neurons during bicuculline-induced epileptiform activity, both in the control and after the addition of 30 µM BAPTA-AM. BAPTA-AM was added at 270 s. In both cases, BAPTA-AM caused an increase in the frequency of AP bursts, from 0.08–0.1 Hz to 0.2–0.3 Hz on average. In both types of neurons, a small depolarization (10–12 mV) is observed during BAPTA accumulation (Figure 3A and Figure 4A). The amplitude of the first AP in each cluster does not change, indicating that the cell membrane is intact and Na+ gradients are maintained. Since the depolarization effect occurs as BAPTA accumulates rather than immediately, inhibition occurs on the inner side of the membrane. The figures also show a gradual increase in the frequency of AP bursts. If slow depolarization results from K+ channel inhibition by BAPTA-AM, then its effect should be washed off, as illustrated in Figure 4A. The effect of the increased frequency of clusters is also washed away. The slow depolarization that grows as BAPTA accumulates appears to be the result of BAPTA-AM inhibiting the K+ channel [25,26], since the effect is washed out in both potential and frequency.
Figure 3B–F and Figure 4B–F illustrate the changes in PDS cluster structure in glutamatergic and GABAergic neurons, respectively, as BAPTA accumulates. In the glutamate neuron, the cluster amplitude exceeds −20 mV (see Figure 1A). A single action potential (AP) is generated at the leading edge of the PDS. The PDS cluster duration decreases as BAPTA accumulates, from 9 PDS to 1 PDS (from 1.43 s to 0.15 s), but the amplitude remains unchanged. After that, the pulsations will stop.
Figure 4B–E show changes in PDS clusters during BAPTA accumulation in a selected GABAergic neuron. Figure 4B shows the control PDS cluster taken from Figure 4A, which was recorded before BAPTA addition. After incubation with BAPTA-AM only 2–3 min (Figure 4C), there is a sharp decrease in the PDS cluster amplitude and a slowing of the leading edge of the burst. This results in a switch in PDS cluster mode to burst mode, which exhibits the classic inverse relationship between AP amplitude and slow depolarization amplitude (Figure 4D). After washing, the effect of BAPTA-AM was maintained (Figure 4E,F).
A comparison of PDS clusters in the presence and absence of BAPTA in a glutamatergic neuron (Figure 5) showed that cluster durations and their associated APs were maximally suppressed (red curve). Previous studies have shown that Kv7-type potassium channels are involved in regulating cluster duration [27]. Figure 6 shows that the Kv7 activator retigabine decreases cluster duration without significantly affecting amplitude. It is likely that BAPTA’s effect is also due to Kv7 activation. Kv7 activity is known to be inhibited by CaCaM [28,29], which appears to be impaired in the presence of BAPTA.
Thus, the main effect of the intracellular fast calcium buffer in glutamate neurons is to reduce the duration of the PDS cluster. In contrast, in GABAergic neurons, the calcium buffer promotes a shift in cluster activity to classical AP bursts by reducing cluster amplitude. These mechanisms both explain the neuroprotective effect of intracellular Ca2+ buffers and may contribute to the transition from epileptiform to developmental rhythms.

3. Discussion

This study demonstrates that the fast-binding calcium buffer plays an active role in forming AP burst patterns and regulates the rhythm of neuronal burst activity. It does so by regulating the amplitude and duration of PDS clusters and calcium pulses. The clusters’ frequency and duration are not constant in the control group and fluctuate chaotically around a certain value. This behavior suggests the involvement of a stochastic process in both impulse generation and cluster duration regulation. This process involves the generation and addition of hundreds of elementary postsynaptic impulses. Typically, neighboring clusters differ in duration by 1 PDS.
Figure 3A and Figure 4A demonstrate that BAPTA-AM increases the oscillation frequency, corresponding to depolarization-dependent neuronal excitation. As previously demonstrated, this effect may be related to BAPTA-AM’s inhibition of the potassium channel [30]. Since this effect develops over time, the inhibition appears to occur on the inner side of the membrane.
In glutamatergic neurons, BAPTA rapidly decreased the duration of the PDS cluster without significantly affecting amplitude. This helps maintain the rhythm within a safe range of other parameters, such as frequencies. Reducing cluster duration is critical because it determines the duration of the Ca2+ pulse. This reduction is observed in the action of many neuroprotective compounds [22,31].
The pulse duration is determined by the lifetime of the control potassium and calcium channels. However, Ca2+ channels also alter the amplitude of the signal. The mechanism by which signal duration decreases without amplitude suppression may be related to the activation of low-threshold Kv7-type potassium channels [32], whose activity is controlled by PIP2 [33,34], the βγ subunit, CaCaM, and phosphorylation [35]. Since an increase in either of the first two is unlikely in the presence of BAPTA, activation by decreasing CaCaM seems to occur in this case.
Unlike glutamatergic neurons, the signal duration of GABAergic neurons decreased insignificantly during BAPTA accumulation. However, the amplitude of PDS clusters decreased significantly (Figure 4B–F). This resulted in a switch to the classical burst mode, which increased the electrical activity of the neuron (i.e., increased AP amplitude). This latter effect appears to be close to the physiological effect, as the presence of fast CBPs in GABAergic neurons has been demonstrated and is even a marker for them [36]. The effect is similar to that of AP-5, an NMDAR inhibitor that reduces the depolarizing current across the postsynaptic membrane [1]. It is also shown there that a decrease in the amplitude of PDS clusters is accompanied by a switch to classical burst activity and an increase in AP amplitude. In our case, Ca2+ currents across the membrane can only decrease through attenuation of the calcium-dependent Ca2+ release from the ER, which triggers the depolarizing current. The steepness of the leading edge of the clusters is proportional to the Ca2+ current and decreases in the presence of BAPTA in both types of neurons.
Most of the experimental data indicates that calcium channels and calcium ions are among the main regulators of PDS clusters [15,22,37,38]. These channels participate in generating both low-amplitude, slow depolarizing pulses and high-amplitude depolarizing pulses that induce neurotransmitter release. Furthermore, calcium currents and [Ca2+]i control the opposing processes of depolarization and hyperpolarization, respectively. The regulation of bursting activity (including PDS clusters) by Ca2+ ions is assumed to target both excitation and inhibition. Accordingly, it consists of two processes: the depolarizing (excitatory) effect of Ca2+ currents occurs through the opening of various Ca2+ channels in the plasma membrane and synapses; the hyperpolarizing (inhibitory) effect occurs through the opening of calcium-dependent K+ and Cl channels and the activation of GABA release. Clearly, the inhibitory effect occurs with a delay relative to the excitatory, as it takes time to change [Ca2+]i. Thus, for the first time, it has been shown that an intracellular fast Ca2+ buffer suppresses the epileptiform activity of neurons. Intracellular fast Ca2+ buffer decreases the duration of AP bursts (PDS clusters) in glutamate neurons and reduces the amplitude of PDS clusters in GABAergic neurons. The decrease in AP burst duration (PDS cluster duration) in glutamate neurons is assumed to result from the activation of low-threshold, slow-inactivating, voltage-dependent Kv7 channels [32]. Decreasing the duration of PDS clusters in glutamate neurons and decreasing the amplitude of PDS clusters in GABAergic neurons may contribute to generating a recovery rhythm.
In the future, we aim to control the rhythm of neural network development and recovery after damage. This work shows that intracellular fast Ca2+ binding proteins can be involved in this process. We will use the filling of Ca2+ buffers in inhibitory neurons to switch the epileptic rhythm into the rhythm of neural network recovery after brain injury.

4. Materials and Methods

4.1. Cell Culture

In the present experiments, epileptiform activity was induced in hippocampal cell culture by the GABA(A) receptor inhibitor bicuculline. Neuron-glial cultures were derived from the hippocampi of newborn Wistar rats (P0–2), as described earlier [21,24,39]. Wistar pups (P0–2) of both sexes were euthanized with deep-inhaled anesthesia and decapitated. (Original source—animal facility of The Branch of the IBCh RAS in Pushchino; RRID: Not registered). Cultures were grown in a CO2 incubator at 37 °C and 95% humidity for two weeks and then were used in experiments. We used 12–14 DIV cultures in all experiments. The concentration of BAPTA AM was selected experimentally. In other experiments, BAPTA was used at concentrations of 10, 25, and 50 μM. Lower concentrations did not affect the pulse parameters, while higher concentrations caused rapid inhibition of pulsations. The relationship between the dose and the effect of intracellular BAPTA is evident when BAPTA is accumulated during the experiment.

4.2. Fluorescent [Ca2+]i Measurements

Hippocampal cell cultures were stained with Fluo-8/AM (AAT Bioquest, Inc. (Pleasanton, CA, USA)/FluoriCa-8 AM (Lumiprobe RUS, Moscow, Russia), dissolved in Hank’s Balanced Salt Solution (HBSS), consisting of (mM): 136 NaCl, 3 KCl, 0.8 MgSO4, 1.25 KH2PO4, 0.35 Na2HPO4, 1.4 CaCl2, 10 glucose, and 10 HEPES; pH 7.35. The cells were incubated with the probe at 28–30 °C for 40 min (working concentration 3 µM). The neurons were subsequently washed with HBSS and incubated for a minimum of 10 min in fresh culture medium. The excitation wavelength for Fluo-8/AM was 490 nm, and the emission wavelength was 525 nm. All imaging experiments were performed at 28–30 °C. The fluctuations in [Ca2+]i were recorded using an inverted motorized microscope Leica DMI6000B (Leica Microsystems, Wetzlar, Germany), equipped with a high-speed monochrome CCD camera HAMAMATSU C9100 (Hamamatsu Photonics K.K., Hamamatsu City, Japan) and a high-speed excitation filter wheel system from Leica’s Ultra-Fast Filter Wheels. A Leica HC PL APO 20×/0.7 IMM objective (Leica Microsystems, Wetzlar, Germany) was used. The excitation source for fluorescence was a Leica EL6000 illuminator with a high-pressure mercury lamp HBO 103 W/2 (Leica Microsystems, Wetzlar, Germany). For fluorescence measurement, a round coverslip with the cell culture stained with Fluo-8 was mounted in a special measurement chamber. The volume of HBSS in the chamber was 1 mL. Reagent additions and washouts were performed by changing the medium to a five-fold volume using a system that provided perfusion at a rate of 15 mL/min.
The fluorescence intensity was collected from the soma during the analysis of the time-lapse series. The mean background fluorescence for each series of images was obtained by averaging the signals collected from 10 ROIs set on the areas of the culture without soma and processes of the cells, and the obtained mean background fluorescence kinetics (baselines) were subtracted from the corresponding signal of each analyzed cell. Changes in [Ca2+]i are presented as (ΔF/F) and were calculated in ImageJ (NIH, Bethesda, MD, USA, https://imagej.net/ij/) programming environment to generate single-neuron activity traces. The results are presented as representative recordings of calcium signals in individual cells.

4.3. Electrophysiological Measurements

Experiments using the patch-clamp technique in whole-cell configuration were carried out on fluorescent station with built-in microincubator and electrophysiological patch-clamp setup equipped with a Hamamatsu ORCA-Flash camera. Electrophysiological characteristics of neurons were recorded at 28 °C using an Axopatch 200B amplifier (Axon Instruments, Union City, CA, USA). Data were digitized using a low-noise data acquisition system (Axon DigiData 1440A digital converter) (Molecular Devices, San Jose, CA, USA) with pCLAMP 10 software from Axon Instruments (USA). Glass capillaries made from borosilicate glass (outer diameter 1.5 mm, inner diameter 0.06 mm, length 10 cm, manufactured by Sutter Instrument, Novato, CA, USA) were used to make micropipettes. Pipettes were pulled using a Narishige PC-100 puller (Tokyo, Japan). The resistance of the pipette tip was 4–5 MΩ. The internal pipette solution had the following composition (mM): 5 KCl, 130 potassium gluconate, 1 MgCl2 × 6H2O, 0.25 EGTA, 4 HEPES, 2 Na2-ATP, 0.3 Mg-ATP, 0.3 Na-GTP, and 10 Na2-phosphocreatine (305–310 mOsm, pH 7.2). The coverslip with the culture was placed in an experimental chamber containing Hank’s solution (volume of 1 mL). Reagent additions and washouts were performed using a perfusion system similar to the method described above.

4.4. Reagents

The following reagents were used in the experiments: (−)-bicuculline methochloride, ATPA, retigabine (Tocris Bioscience, Bristol, UK), Neurobasal-A medium and B-27 supplement (Thermofisher, Waltham, MA, USA), trypsin (1%) (Life Technologies, Grand Island, NY, USA); and BAPTA-AM (Sigma-Aldrich, Saint Louis, MO, USA), Neurobasal medium (H333), and penicilin-streptomycin (A063) Paneco, Moscow, Russian Federation.
Statistical and data analysis ImageJ software (National Institutes of Health, Bethesda, MD, USA) was used for image analysis. Origin Pro 2021 version 9.8.0.200 was used for graph creation and analysis (OriginLab, Northampton, MA, USA). Electrophysiological data were analyzed using ClampFit 10 software (Molecular Devices, San Jose, CA, USA). All experiments were performed using the cultures from at least 2 to 3 different animals.

Author Contributions

Conceptualization, V.P.Z.; writing—original draft preparation, V.P.Z.; methodology, formal analysis, investigation, and writing—review and editing V.P.Z., I.Y.T., F.V.T. and S.T.T.; performed the experiments, I.Y.T., F.V.T., A.E.M. and B.K.K.; analyzed the data and wrote the manuscript, I.Y.T. and V.P.Z.; supervision V.P.Z. and S.T.T.; funding acquisition, S.T.T. All authors have read and agreed to the published version of the manuscript.

Funding

The current work was funded by a grant from the Science Committee of the Ministry of Science and Higher Education of the Republic of Kazakhstan, Grant No. AP19678607.

Institutional Review Board Statement

All animal procedures were approved by the Bioethics Committee of the Institute of Cell Biophysics (ICB) and carried out according to Act708n (23 August 2010) of the Russian Federation National Ministry of Public Health, which states the rules of laboratory practice for the care and use of laboratory animals, and the Council Directive 2010/63 EU of the European Parliament on the protection of animals used for scientific purposes. ICB RAS Animal Facility provided the animals for experiments in accordance with the applications approved by the Commission on Biosafety and Bioethics of the Institute of Cell Biophysics (Permission No. 6, 12 December 2017; Permission No. 2, 12 June 2020, Permission No. 3, 12 April 2021; Permission No. 4, 17 July 2021, Permission No. 3, 12 February 2022; Permission No. 4, 17 June 2022, Permission No. 3, 12 March 2023).

Data Availability Statement

The original contributions presented in this study are included in the article. Further inquiries can be directed to the corresponding author(s).

Conflicts of Interest

The authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.

Abbreviations

The following abbreviations are used in this manuscript:
BAPTA1,2-bis (o-aminophenoxy) ethane-N,N,N′,N’-tetraacetic acid) selective Ca2+ chelator
ADAlzheimer’s disease
PDParkinson disease
GABAγ-aminobutyric acid
DIVdays in vitro
APaction potential
PDSparoxysmal depolarization shift
ATPAcalcium-permeable kainate receptor agonist, (RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl) propanoic acid
CBPscalcium-binding proteins
CaCaMCalcium–Calmodulin complex
Kv7potassium channels

References

  1. Teplov, I.Y.; Zinchenko, V.P.; Kosenkov, A.M.; Gaidin, S.G.; Nenov, M.N.; Sergeev, A.I. Involvement of NMDA and GABA(A) receptors in modulation of spontaneous activity in hippocampal culture: Interrelations between burst firing and intracellular calcium signal. Biochem. Biophys. Res. Commun. 2021, 553, 99–106. [Google Scholar] [CrossRef]
  2. Kubista, H.; Boehm, S.; Hotka, M. The Paroxysmal Depolarization Shift: Reconsidering Its Role in Epilepsy, Epileptogenesis and Beyond. Int. J. Mol. Sci. 2019, 20, 577. [Google Scholar] [CrossRef]
  3. Kuijlaars, J.; Oyelami, T.; Diels, A.; Rohrbacher, J.; Versweyveld, S.; Meneghello, G.; Tuefferd, M.; Verstraelen, P.; Detrez, J.R.; Verschuuren, M.; et al. Sustained synchronized neuronal network activity in a human astrocyte co-culture system. Sci. Rep. 2016, 6, 36529. [Google Scholar] [CrossRef]
  4. Mohajerani, M.H.; Cherubini, E. Role of giant depolarizing potentials in shaping synaptic currents in the developing hippocampus. Crit. Rev. Neurobiol. 2006, 18, 13–23. [Google Scholar] [CrossRef]
  5. Mohajerani, M.H.; Sivakumaran, S.; Zacchi, P.; Aguilera, P.; Cherubini, E. Correlated network activity enhances synaptic efficacy via BDNF and the ERK pathway at immature CA3 CA1 connections in the hippocampus. Proc. Natl. Acad. Sci. USA 2007, 104, 13176–13181. [Google Scholar] [CrossRef]
  6. Liu, J.; Zhang, P.; Zou, Q.; Liang, J.; Chen, Y.; Cai, Y.; Li, S.; Li, J.; Su, J.; Li, Q. Status of epilepsy in the tropics: An overlooked perspective. Epilepsia Open 2023, 8, 32–45. [Google Scholar] [CrossRef] [PubMed]
  7. Polymeropoulos, M.H.; Higgins, J.J.; Golbe, L.I.; Johnson, W.G.; Ide, S.E.; Di Iorio, G.; Sanges, G.; Stenroos, E.S.; Pho, L.T.; Schaffer, A.A.; et al. Mapping of a gene for Parkinson’s disease to chromosome 4q21-q23. Science 1996, 274, 1197–1199. [Google Scholar] [CrossRef] [PubMed]
  8. Zaltieri, M.; Longhena, F.; Pizzi, M.; Missale, C.; Spano, P.; Bellucci, A. Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? Park. Dis. 2015, 2015, 108029. [Google Scholar] [CrossRef] [PubMed]
  9. Dewan, M.C.; Rattani, A.; Gupta, S.; Baticulon, R.E.; Hung, Y.C.; Punchak, M.; Agrawal, A.; Adeleye, A.O.; Shrime, M.G.; Rubiano, A.M.; et al. Estimating the global incidence of traumatic brain injury. J. Neurosurg. 2018, 130, 1080–1097. [Google Scholar] [CrossRef]
  10. Petrović, G. Faktori rizika u pojavi cerebrovaskularnog insulta [Risk factors for development of cerebrovascular stroke]. Med. Pregl. 2000, 53, 207–214. [Google Scholar]
  11. Ngugi, A.K.; Bottomley, C.; Kleinschmidt, I.; Sander, J.W.; Newton, C.R. Estimation of the burden of active and life-time epilepsy: A meta-analytic approach. Epilepsia 2010, 51, 883–890. [Google Scholar] [CrossRef]
  12. Bacci, A.; Verderio, C.; Pravettoni, E.; Matteoli, M. Synaptic and intrinsic mechanisms shape synchronous oscillations in hippocampal neurons in culture. Eur. J. Neurosci. 1999, 11, 389–397. [Google Scholar] [CrossRef]
  13. Yáñez, M.; Gil-Longo, J.; Campos-Toimil, M. Calcium binding proteins. Adv. Exp. Med. Biol. 2012, 740, 461–482. [Google Scholar]
  14. Carapeto, A.P.; Marcuello, C.; Faísca, P.F.N.; Rodrigues, M.S. Morphological and Biophysical Study of S100A9 Protein Fibrils by Atomic Force Microscopy Imaging and Nanomechanical Analysis. Biomolecules 2024, 14, 1091. [Google Scholar] [CrossRef]
  15. Zhang, S.; Zhu, Y.; Cheng, J.; Tao, J. Ion channels in epilepsy: Blasting fuse for neuronal Hyperexcitability. In Epilepsy—Advances in Diagnosis and Therapy; Al-Zwaini, I.J., Albadri, B.A.-H.M., Eds.; IntechOpen: Rijeka, Croatia, 2019. [Google Scholar]
  16. Zinchenko, V.P.; Turovsky, E.A.; Turovskaya, M.V.; Berezhnov, A.V.; Sergeev, A.I.; Dynnik, V.V. NAD causes dissociation of neural networks into subpopulations of neurons by inhibiting the network synchronous hyperactivity evoked by ammonium ions. Biochem. Moscow Suppl. Ser. A 2016, 10, 118–125. [Google Scholar] [CrossRef]
  17. Schwaller, B. Cytosolic Ca2+ buffers. Cold Spring Harb. Perspect. Biol. 2010, 2, a004051. [Google Scholar] [CrossRef]
  18. Lukas, W.; Jones, K.A. Cortical neurons containing calretinin are selectively resistant to calcium overload and excitotoxicity in vitro. Neuroscience 1994, 61, 307–316. [Google Scholar] [CrossRef]
  19. Kang, K.R.; Kim, J.; Ryu, B.; Lee, S.G.; Oh, M.S.; Baek, J.; Ren, X.; Canavero, S.; Kim, C.Y.; Chung, H.M. BAPTA, a calcium chelator, neuroprotects injured neurons in vitro and promotes motor recovery after spinal cord transection in vivo. CNS Neurosci. Ther. 2021, 27, 919–929. [Google Scholar] [CrossRef]
  20. Laryushkin, D.P.; Maiorov, S.A.; Zinchenko, V.P.; Mal’tseva, V.N.; Gaidin, S.G.; Kosenkov, A.M. Of the Mechanisms of Paroxysmal Depolarization Shifts: Generation and Maintenance of Bicuculline- Induced Paroxysmal Activity in Rat Hippocampal Cell Cultures. Int. J. Mol. Sci. 2023, 24, 10991. [Google Scholar] [CrossRef]
  21. Zinchenko, V.P.; Kosenkov, A.M.; Gaidin, S.G.; Sergeev, A.I.; Dolgacheva, L.P.; Tuleukhanov, S.T. Properties of GABAergic Neurons Containing Calcium-Permeable Kainate and AMPA-Receptors. Life 2021, 11, 1309. [Google Scholar] [CrossRef]
  22. Maiorov, S.A.; Kairat, B.K.; Berezhnov, A.V.; Zinchenko, V.P.; Gaidin, S.G.; Kosenkov, A.M. Peculiarities of ion homeostasis in neurons containing calcium-permeable AMPA receptors. Arch. Biochem. Biophys. 2024, 754, 109951. [Google Scholar] [CrossRef]
  23. Gaidin, S.G.; Kosenkov, A.M.; Zinchenko, V.P.; Kairat, B.K.; Malibayeva, A.E.; Tuleukhanov, S.T. Identification of Neurons Containing Calcium-Permeable AMPA and Kainate Receptors Using Ca2+ Imaging. Bio Protocl 2025, 15, e5199. [Google Scholar] [CrossRef]
  24. Maiorov, S.A.; Zinchenko, V.P.; Gaidin, S.G.; Kosenkov, A.M. Potential mechanism of GABA secretion in response to the activation of GluK1-containing kainate receptors. Neurosci. Res. 2021, 171, 27–33. [Google Scholar] [CrossRef]
  25. Sneyers, F.; Speelman-Rooms, F.; Verhelst, S.H.L.; Bootman, M.D.; Bultynck, G. Cellular effects of BAPTA: Are they only about Ca2+ chelation? Biochim. Biophys. Acta Mol. Cell Res. 2023, 1871, 119589. [Google Scholar] [CrossRef]
  26. Tang, Q.; Jin, M.W.; Xiang, J.Z.; Dong, M.Q.; Sun, H.Y.; Lau, C.P.; Li, G.R. The membrane permeable calcium chelator BAPTA-AM directly blocks human ether a-go-go-related gene potassium channels stably expressed in HEK 293 cells. Biochem. Pharmacol. 2007, 74, 1596–1607. [Google Scholar] [CrossRef]
  27. Zinchenko, V.P.; Teplov, I.Y.; Kosenkov, A.M.; Gaidin, S.G.; Kairat, B.K.; Tuleukhanov, S.T. Participation of calcium-permeable AMPA receptors in the regulation of epileptiform activity of hippocampal neurons. Front. Synaptic Neurosci. 2024, 16, 1349984. [Google Scholar] [CrossRef]
  28. Gomis-Perez, C.; Soldovieri, M.V.; Malo, C.; Ambrosino, P.; Taglialatela, M.; Areso, P.; Villarroel, A. Differential Regulation of PI(4,5)P2 Sensitivity of Kv7.2 and Kv7.3 Channels by Calmodulin. Front. Mol. Neurosci. 2017, 10, 117. [Google Scholar] [CrossRef]
  29. Yang, X.; Chen, S.; Zhang, S.; Shi, S.; Zong, R.; Gao, Y.; Guan, B.; Gamper, N.; Gao, H. Intracellular zinc protects Kv7 K+ channels from Ca2+/calmodulin-mediated inhibition. J. Biol. Chem. 2023, 299, 102819. [Google Scholar] [CrossRef]
  30. Watkins, C.S.; Mathie, A. Effects on K+ currents in rat cerebellar granule neurones of a membrane-permeable analogue of the calcium chelator BAPTA. Br. J. Pharmacol. 1996, 118, 1772–1778. [Google Scholar] [CrossRef]
  31. Maiorov, S.A.; Laryushkin, D.P.; Kritskaya, K.A.; Zinchenko, V.P.; Gaidin, S.G.; Kosenkov, A.M. The Role of Ion Channels and Intracellular Signaling Cascades in the Inhibitory Action of WIN 55,212-2 upon Hyperexcitation. Brain Sci. 2024, 14, 668. [Google Scholar] [CrossRef]
  32. Greene, D.L.; Hoshi, N. Modulation of Kv7 channels and excitability in the brain. Cell. Mol. Life Sci. 2017, 74, 495–508. [Google Scholar] [CrossRef]
  33. Zaydman, M.A.; Cui, J. PIP2 regulation of KCNQ channels: Biophysical and molecular mechanisms for lipid modulation of voltage-dependent gating. Front. Physiol. 2014, 5, 195. [Google Scholar] [CrossRef]
  34. Taylor, K.C.; Sanders, C.R. Regulation of KCNQ/Kv7 family voltage-gated K+ channels by lipids. Biochim. Biophys. Acta Biomembr. 2017, 1859, 586–597. [Google Scholar] [CrossRef]
  35. van der Horst, J.; Greenwood, I.A.; Jepps, T.A. Cyclic AMP-Dependent Regulation of Kv7 Voltage-Gated Potassium Channels. Front. Physiol. 2020, 11, 727. [Google Scholar] [CrossRef] [PubMed]
  36. Hladnik, A.; Džaja, D.; Darmopil, S.; Jovanov-Milošević, N.; Petanjek, Z. Spatio-temporal extension in site of origin for cortical calretinin neurons in primates. Front. Neuroanat. 2014, 8, 50. [Google Scholar] [CrossRef]
  37. Gaidin, S.G.; Maiorov, S.A.; Laryushkin, D.P.; Zinchenko, V.P.; Kosenkov, A.M. A novel approach for vital visualization and studying of neurons containing Ca2+ -permeable AMPA receptors. J. Neurochem. 2023, 164, 583–597. [Google Scholar] [CrossRef] [PubMed]
  38. Laryushkin, D.P.; Maiorov, S.A.; Zinchenko, V.P.; Gaidin, S.G.; Kosenkov, A.M. Role of L-Type Voltage-Gated Calcium Channels in Epileptiform Activity of Neurons. Int. J. Mol. Sci. 2021, 22, 10342. [Google Scholar] [CrossRef] [PubMed]
  39. Gaidin, S.G.; Zinchenko, V.P.; Kosenkov, A.M. Mechanisms of ammonium-induced neurotoxicity. Neuroprotective effect of alpha-2 adrenergic agonists. Arch. Biochem. Biophys. 2020, 693, 108593. [Google Scholar] [CrossRef]
Figure 1. (A) PDS cluster of glutamatergic neurons. (B) PDS cluster of GABAergic neurons.
Figure 1. (A) PDS cluster of glutamatergic neurons. (B) PDS cluster of GABAergic neurons.
Ijms 26 07596 g001
Figure 2. (A) Spontaneously pulsing neurons. [Ca2+]i changes in GABAergic neurons (highlighted in red) and in glutamatergic neurons (highlighted in blue-green-gray) upon successive addition of ATPA (500 nM), bicuculline (20 µM), and BAPTA-AM (30 µM). In this experiment, 60 out of 210 neurons in the field of view responded to ATPA. (B) Initial part of the subfigure (A). ATPA causes a [Ca2+]i increase in GABAergic neurons (3 of which are highlighted in red). ATPA inhibits [Ca2+]i pulses in glutamate neurons. Pause 10 min.
Figure 2. (A) Spontaneously pulsing neurons. [Ca2+]i changes in GABAergic neurons (highlighted in red) and in glutamatergic neurons (highlighted in blue-green-gray) upon successive addition of ATPA (500 nM), bicuculline (20 µM), and BAPTA-AM (30 µM). In this experiment, 60 out of 210 neurons in the field of view responded to ATPA. (B) Initial part of the subfigure (A). ATPA causes a [Ca2+]i increase in GABAergic neurons (3 of which are highlighted in red). ATPA inhibits [Ca2+]i pulses in glutamate neurons. Pause 10 min.
Ijms 26 07596 g002
Figure 3. (A) Changes in the membrane potential of glutamatergic neurons in epileptiform activity mode in response to 30 μM BAPTA-AM added after 270 s. PDS cluster: (B) in control; (C) 120 s incubation with BAPTA; (D) 149 s incubation with BAPTA; (E) 152 s incubation with BAPTA; and (F) 178 s incubation with BAPTA.
Figure 3. (A) Changes in the membrane potential of glutamatergic neurons in epileptiform activity mode in response to 30 μM BAPTA-AM added after 270 s. PDS cluster: (B) in control; (C) 120 s incubation with BAPTA; (D) 149 s incubation with BAPTA; (E) 152 s incubation with BAPTA; and (F) 178 s incubation with BAPTA.
Ijms 26 07596 g003
Figure 4. (A) Changes in the membrane potential of GABAergic neurons in epileptiform activity mode in response to 30 μM BAPTA-AM added after 270 s. PDS cluster: (B) in control; (C) 120 s incubation with BAPTA; (D) 211 s incubation with BAPTA; (E) 45 s after washing from BAPTA; and (F) 54 s after washing from BAPTA.
Figure 4. (A) Changes in the membrane potential of GABAergic neurons in epileptiform activity mode in response to 30 μM BAPTA-AM added after 270 s. PDS cluster: (B) in control; (C) 120 s incubation with BAPTA; (D) 211 s incubation with BAPTA; (E) 45 s after washing from BAPTA; and (F) 54 s after washing from BAPTA.
Ijms 26 07596 g004
Figure 5. Comparison of PDS clusters in glutamatergic neuron in control (black curve) and after 3 min incubation with BAPTA-AM (red curve).
Figure 5. Comparison of PDS clusters in glutamatergic neuron in control (black curve) and after 3 min incubation with BAPTA-AM (red curve).
Ijms 26 07596 g005
Figure 6. PDS cluster in glutamatergic neuron in control (black curve) and in the presence of Kv7 channel activator retigabine (2.5 μM) (red curve).
Figure 6. PDS cluster in glutamatergic neuron in control (black curve) and in the presence of Kv7 channel activator retigabine (2.5 μM) (red curve).
Ijms 26 07596 g006
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Zinchenko, V.P.; Teplov, I.Y.; Tyurin, F.V.; Malibayeva, A.E.; Kairat, B.K.; Tuleukhanov, S.T. The Effect of Intracellular Calcium Buffer Bapta on Epileptiform Activity of Hippocampal Neurons. Int. J. Mol. Sci. 2025, 26, 7596. https://doi.org/10.3390/ijms26157596

AMA Style

Zinchenko VP, Teplov IY, Tyurin FV, Malibayeva AE, Kairat BK, Tuleukhanov ST. The Effect of Intracellular Calcium Buffer Bapta on Epileptiform Activity of Hippocampal Neurons. International Journal of Molecular Sciences. 2025; 26(15):7596. https://doi.org/10.3390/ijms26157596

Chicago/Turabian Style

Zinchenko, V. P., I. Yu. Teplov, F. V. Tyurin, A. E. Malibayeva, B. K. Kairat, and S. T. Tuleukhanov. 2025. "The Effect of Intracellular Calcium Buffer Bapta on Epileptiform Activity of Hippocampal Neurons" International Journal of Molecular Sciences 26, no. 15: 7596. https://doi.org/10.3390/ijms26157596

APA Style

Zinchenko, V. P., Teplov, I. Y., Tyurin, F. V., Malibayeva, A. E., Kairat, B. K., & Tuleukhanov, S. T. (2025). The Effect of Intracellular Calcium Buffer Bapta on Epileptiform Activity of Hippocampal Neurons. International Journal of Molecular Sciences, 26(15), 7596. https://doi.org/10.3390/ijms26157596

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop